Company: HCTI
Filing Date: 2025-11-19
Form Type: 8-K
Source: 0001213900-25-112546
Chunk: 0

Company: Healthcare Triangle, Inc.
Filing Date: 2025-11-19
Form: 8-K
Item: Item 1.01
Chunk 0
---
Item 1.01. Entry into a Material Definitive
Agreement.

On November 18, 2025,
Healthcare Triangle, Inc., a Delaware corporation, (the “ Company”), entered into a Sales Agreement (the “ Agreement”)
with Spartan Capital Securities, LLC (“ Spartan”), as sales agent providing for the sale by the Company of shares of its common
stock, par value $0.00001 per share (the “ Common Stock”), from time to time, in an “at the market offering” program
through Spartan with certain limitations on the amount of Common Stock that may be offered and sold by the Company as set forth in the
Agreement (the “ Offering”). The sales, if any, of the shares of Common Stock made under the Agreement will be made by any
method permitted by law deemed to be an “at the market offering” as defined in Rule 415 promulgated under the Securities Act
of 1933, as amended (the “ Securities Act”), including sales made directly on or through the Nasdaq Capital Market or on any
other existing trading market for the Common Stock, in negotiated transactions at market prices prevailing at the time
of sale or at prices related to such prevailing market prices, and/or in any other method permitted by law.

The shares
of Common Stock, if any, will be issued pursuant to a prospectus supplement, dated November 18, 2025 (the “ Prospectus Supplement”),
and an accompanying base prospectus, dated January 31, 2024, contained therein, which together form a part of the Company’s “shelf”
registration statement on Form S-3 (File No. 333-276382) filed by the Company with the Securities and Exchange Commission (“ SEC”)
on January 5, 2024 and declared effective by the SEC on January 31, 2024. The aggregate market value of the shares of Common Stock eligible
for sale under the Prospectus Supplement is currently $20,000,000.

Under the Agreement, the Company will set
the parameters for the sale of shares, including the number of shares to be sold, the time period during which sales are requested
to be made, limitation on the number of shares that may be sold in any one trading day and any minimum price below which sales may
not be made. Subject to the terms and conditions of the Agreement, Spartan may sell the shares by methods deemed to be an “at
the market offering” as defined in Rule